Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.33 |
| ▸ | BCHE | P06276 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17348014 | 0.82 | CA1 (0.33) | CA2CA1CA9PTGS2 | |
| SCHEMBL68796 | 0.80 | GAA (0.43) | CA2CA1CA9BCHEACHE | |
| SCHEMBL21595326 | 0.78 | PTGS2 (0.49) | CA2CA1CA9PTGS2BCHE | |
| SCHEMBL15895016 | 0.76 | PLCG1 (0.44) | CA2CA1CA9PTGS2 | |
| SCHEMBL2270234 | 0.75 | CA1 (0.43) | CA2CA1CA9PTGS2 | |
| SCHEMBL15895019 | 0.73 | CA2 (0.38) | CA2CA1CA9PTGS2 | |
| SCHEMBL14382995 | 0.72 | TDP1 (0.46) | CA2CA1CA9PTGS2 | |
| SCHEMBL14973316 | 0.72 | CA1 (0.42) | CA2CA1CA9PTGS2BCHE | |
| SCHEMBL9040346 | 0.71 | LMNA (0.47) | — | |
| SCHEMBL14972994 | 0.71 | MMP1 (0.35) | CA2CA1CA9PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9920082-B2 | Water-soluble complexing agents and corresponding lanthanide complexes | CISBO BIOASSAYS (FR) | 2018-03-20 | — | — | US | disclosed |
| US-20150361116-A1 | NOVEL WATER-SOLUBLE COMPLEXING AGENTS AND CORRESPONDING LANTHANIDE COMPLEXES | CISBIO BIOASSAYS (FR) | 2015-12-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150361116-A1 | NOVEL WATER-SOLUBLE COMPLEXING AGENTS AND CORRESPONDING LANTHANIDE COMPLEXES | RCC1, CLIC1, RCC2 | CA2 21/4885CA1 204/4885CA9 149/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.